Blue Jet Healthcare [BLUEJET] vs Biocon [BIOCON] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Blue Jet Healthcare Ltd. wins in 9 metrics, Biocon Ltd. wins in 11 metrics, with 0 ties. Biocon Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Blue Jet Healthcare Ltd. | Biocon Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.87 | 71.84 | Blue Jet Healthcare Ltd. |
| Price-to-Book Ratio | 5.56 | 1.68 | Biocon Ltd. |
| Debt-to-Equity Ratio | 1.64 | 50.02 | Blue Jet Healthcare Ltd. |
| PEG Ratio | -0.77 | 0.17 | Biocon Ltd. |
| EV/EBITDA | 18.91 | 19.22 | Blue Jet Healthcare Ltd. |
| Profit Margin (TTM) | 27.88% | 3.59% | Blue Jet Healthcare Ltd. |
| Operating Margin (TTM) | 21.26% | 7.63% | Blue Jet Healthcare Ltd. |
| EBITDA Margin (TTM) | 21.26% | 7.63% | Blue Jet Healthcare Ltd. |
| Return on Equity | 26.93% | 3.66% | Blue Jet Healthcare Ltd. |
| Return on Assets (TTM) | 21.53% | 1.72% | Blue Jet Healthcare Ltd. |
| Free Cash Flow (TTM) | $-341.15M | $17.18B | Biocon Ltd. |
| Dividend Yield | 0.22% | 0.26% | Biocon Ltd. |
| 1-Year Return | -46.26% | 17.90% | Biocon Ltd. |
| Price-to-Sales Ratio (TTM) | 6.64 | 3.37 | Biocon Ltd. |
| Enterprise Value | $65.92B | $643.51B | Biocon Ltd. |
| EV/Revenue Ratio | 6.26 | 3.82 | Biocon Ltd. |
| Gross Profit Margin (TTM) | 51.75% | 67.91% | Biocon Ltd. |
| Revenue per Share (TTM) | $61 | $133 | Biocon Ltd. |
| Earnings per Share (Diluted) | $16.90 | $4.87 | Blue Jet Healthcare Ltd. |
| Beta (Stock Volatility) | 0.37 | 0.25 | Biocon Ltd. |
Blue Jet Healthcare Ltd. vs Biocon Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Blue Jet Healthcare Ltd. | -1.60% | 11.86% | 17.17% | 41.50% | -8.00% | -4.67% |
| Biocon Ltd. | -0.70% | 1.66% | -3.27% | 10.34% | 6.50% | 7.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Blue Jet Healthcare Ltd. | -46.26% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% |
| Biocon Ltd. | 17.90% | 71.09% | 5.03% | 250.57% | 603.49% | 1,357.39% |
Performance & Financial Health Analysis: Blue Jet Healthcare Ltd. vs Biocon Ltd.
| Metric | BLUEJET | BIOCON |
|---|---|---|
| Market Information | ||
| Market Cap | ₹69.97B | ₹566.52B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 473,848 | 2,496,867 |
| 90 Day Avg. Volume | 572,203 | 3,790,310 |
| Last Close | ₹504.30 | ₹416.05 |
| 52 Week Range | ₹325.00 - ₹1,027.80 | ₹331.00 - ₹440.40 |
| % from 52W High | -50.93% | -5.53% |
| All-Time High | ₹1,027.80 (Jul 21, 2025) | ₹487.75 (Dec 21, 2020) |
| % from All-Time High | -50.93% | -14.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.40% | 0.09% |
| Quarterly Earnings Growth | -0.59% | 4.73% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | 0.04% |
| Operating Margin (TTM) | 0.21% | 0.08% |
| Return on Equity (TTM) | 0.27% | 0.04% |
| Debt to Equity (MRQ) | 1.64 | 50.02 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹72.50 | ₹207.92 |
| Cash per Share (MRQ) | ₹23.76 | ₹45.84 |
| Operating Cash Flow (TTM) | ₹899.31M | ₹17.78B |
| Levered Free Cash Flow (TTM) | ₹3.05B | ₹10.13B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.22% | 0.26% |
| Last 12-Month Dividend | ₹1.20 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Blue Jet Healthcare Ltd. vs Biocon Ltd.
| Metric | BLUEJET (Apr 26, 2026) | BIOCON (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.87 | 71.84 |
| Forward P/E | 22.70 | 38.56 |
| PEG Ratio | -0.77 | 0.17 |
| Price to Sales (TTM) | 6.64 | 3.37 |
| Price to Book (MRQ) | 5.56 | 1.68 |
| Market Capitalization | ||
| Market Capitalization | ₹69.97B | ₹566.52B |
| Enterprise Value | ₹65.92B | ₹643.51B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.26 | 3.82 |
| Enterprise to EBITDA | 18.91 | 19.22 |
| Risk & Other Metrics | ||
| Beta | 0.37 | 0.25 |
| Book Value per Share (MRQ) | ₹72.50 | ₹207.92 |
Financial Statements Comparison: Blue Jet Healthcare Ltd. vs Biocon Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BLUEJET (2025) | BIOCON (2025) |
|---|---|---|
| Revenue/Sales | 10.26B | 150.52B |
| Cost of Goods Sold | 4.70B | 51.98B |
| COGS % of Revenue | 45.8% | 34.5% |
| Gross Profit | 5.56B | 98.54B |
| Gross Margin | 54.2% | 65.5% |
| Research & Development | 15.52M | 6.34B |
| Operating Income (EBIT) | 3.60B | 16.26B |
| Operating Margin | 35.1% | 10.8% |
| EBITDA | 4.05B | 33.60B |
| EBITDA Margin | 39.5% | 22.3% |
| Pre-Tax Income | 4.06B | 18.87B |
| Pre-Tax Income % of Revenue | 39.6% | 12.5% |
| Income Tax | 1.01B | 4.57B |
| Income Tax % of Revenue | 9.8% | 3.0% |
| Net Income (Profit) | 3.05B | 14.29B |
| Profit Margin | 29.7% | 9.5% |
Balance Sheet & Liquidity Metrics
| Metric | BLUEJET (2025) | BIOCON (2025) |
|---|---|---|
| Cash & Equivalents | 329.79M | 32.27B |
| Total Current Assets | 10.06B | 162.86B |
| Total Current Assets % of Revenue | 98.0% | 108.2% |
| Total Current Liabilities | 2.56B | 143.34B |
| Total Current Liabilities % of Revenue | 24.9% | 95.2% |
| Long-Term Debt | 165.26M | 129.45B |
| Long-Term Debt % of Revenue | 1.6% | 86.0% |
| Total Shareholders Equity | 11.33B | 277.13B |
| Retained Earnings | 10.98B | 189.59B |
| Retained Earnings % of Revenue | 107.0% | 126.0% |
| Property, Plant & Equipment | 212.65M | 4.32B |
Cash Flow Statement Comparison
| Metric | BLUEJET (2025) | BIOCON (2025) |
|---|---|---|
| Operating Cash Flow | 899.31M | 17.78B |
| Operating Cash Flow % of Revenue | 8.8% | 11.8% |
| Capital Expenditures | -794.98M | -21.36B |
| Free Cash Flow | -341.15M | 17.18B |
| FCF Margin | -3.3% | 11.4% |
| Debt Repayment | N/A | -97.70B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BLUEJET | BIOCON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 173.47M | 1.62B |
| Float Shares | 33.13M | 583.07M |
| % Held by Insiders | 79.81% | 54.07% |
| % Held by Institutions | 1.90% | 24.88% |
| % Held by Public | 18.29% | 21.05% |
Dividend Analysis & Yield Comparison: Blue Jet Healthcare Ltd. vs Biocon Ltd.
| Metric | BLUEJET | BIOCON |
|---|---|---|
| Last 12-Month Dividend | ₹1.20 | ₹1.00 |
| Last 12-Month Dividend Yield | 0.22% | 0.26% |
| 3-Year Avg Annual Dividend | ₹0.73 | ₹1.33 |
| 3-Year Avg Dividend Yield | 0.19% | 0.36% |
| 3-Year Total Dividends | ₹2.20 | ₹4.00 |
| Ex-Dividend Date | Sep 19, 2025 | Jul 04, 2025 |